Publication:
Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: Association with liver fibrosis

dc.contributor.authorÇELİKEL, ÇİĞDEM
dc.contributor.authorYILMAZ, YUSUF
dc.contributor.authorsYilmaz, Yusuf; Kurt, Ramazan; Yonal, Oya; Polat, Nihat; Celikel, Cigdem Ataizi; Gurdal, Ahmet; Oflaz, Huseyin; Ozdogan, Osman; Imeryuz, Nese; Kalayci, Cem; Avsar, Erol
dc.date.accessioned2022-03-12T17:48:14Z
dc.date.accessioned2026-01-11T10:58:44Z
dc.date.available2022-03-12T17:48:14Z
dc.date.issued2010
dc.description.abstractBackground: Nonalcoholic fatty liver disease (NAFLD) is associated with an increased risk of cardiovascular disease. Coronary flow reserve (CFR) is widely used to examine the integrity of coronary microvascular circulation. We evaluated the prevalence of impaired CFR in patients with biopsy-proven NAFLD. We also investigated the independent clinical, biochemical, and liver histology predictors of CFR in the setting of NAFLD. Methods: Fifty-nine consecutive patients with NAFLD and 77 age- and gender-matched controls were evaluated. CFR recordings were performed by transthoracic Doppler harmonic echocardiography. CFR >= 2.0 was considered normal. Results: CFR was significantly lower in patients with NAFLD than in controls (2.11 +/- 0.45 vs. 2.52 +/- 0.62, P < 0.001). An impaired CFR (i.e. < 2) was found in 25 NAFLD patients (42.4%) whereas all controls had normal CFR values (P < 0.001). A stepwise linear regression analysis in NAFLD patients identified liver fibrosis scores as the only independent predictor of CFR values (beta = -0.60; t = -2.44, P = 0.021). Conclusion: Our findings indicate that in patients with biopsy-proven NAFLD: (a) an abnormal CFR is found in approximately 42.4% of cases, and (b) liver fibrosis scores are an independent predictor of depressed CFR. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
dc.identifier.doi10.1016/j.atherosclerosis.2010.01.049
dc.identifier.eissn1879-1484
dc.identifier.issn0021-9150
dc.identifier.pubmed20181335
dc.identifier.urihttps://hdl.handle.net/11424/229920
dc.identifier.wosWOS:000279530000034
dc.language.isoeng
dc.publisherELSEVIER IRELAND LTD
dc.relation.ispartofATHEROSCLEROSIS
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectTransthoracic Doppler harmonic echocardiography
dc.subjectCoronary flow reserve
dc.subjectNonalcoholic fatty liver disease
dc.subjectLiver biopsy
dc.subjectSERUM ADIPONECTIN LEVELS
dc.subjectINTIMA-MEDIA THICKNESS
dc.subjectENDOTHELIAL DYSFUNCTION
dc.subjectHYPERTENSIVE PATIENTS
dc.subjectMETABOLIC SYNDROME
dc.subjectABNORMALITIES
dc.titleCoronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: Association with liver fibrosis
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage186
oaire.citation.issue1
oaire.citation.startPage182
oaire.citation.titleATHEROSCLEROSIS
oaire.citation.volume211

Files